News

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...
Seizures of potentially dangerous weight loss drugs being sold on the black market in Scotland have soared as online dealers ...
Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...
Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...
‘The face has a layer of fat that essentially stretches the skin. Ozempic results in rapid weight loss and does so very ...
Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...
Ozempic, or semaglutide, saw the most staggering increase — from $0.4 billion in 2018 to $26.4 billion in 2023, or a 6,500% increase. Trulicity, or dulaglutide, increased from $5.6 billion to $17.6 ...
A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD.
A man who lost over three stone in as many months via the weight loss medicine Mounjaro has admitted to making a 'big mistake ...
A man who lost over three stone in as many months via the weight loss medicine Mounjaro has admitted to making a 'big mistake ...
The first trial, PIONEER 4, set the new drug against Novo’s own product, injectable once a week Victoza. Semaglutide performed better than expected against Victoza. The results included ...